Later on, Aizarani et al. (2019) sequenced CD45+ and CD45− cells isolated from hepatocellular carcinomas from three patients showing how the gene expression signatures and biomarkers of liver cell types can be monitored in human liver disease. This evidence concerns the gene PTPRC and hepatocellular carcinoma.